EA
DXCM icon

Emerald Acquisition’s DexCom DXCM Stock Holding History

Emerald Acquisition’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$47.5M Sell
2,168,280
-220,692
-9% -$4.91M 0.09% 255
2016
Q2 		$47.3M Buy
+2,388,972
New +$40.7M 0.08% 286

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Emerald Acquisition's DXCM Position: Q3 2016 in Review

Emerald Acquisition reduced its DexCom (DXCM) stake by 9.2% in Q3 2016, selling an estimated $4.91M and leaving 2,168,280 shares worth $47.5M. The position accounts for 0.09% of the portfolio, ranked #255.

Emerald Acquisition first reported a position in DXCM in Q2 2016 and has held it in 2 quarters since. 289 funds tracked by Wall St. Rank hold DXCM as of Q3 2016.

  • Emerald Acquisition held 2,168,280 shares of DexCom worth $47.5M as of Q3 2016.
  • Emerald Acquisition sold 220,692 DexCom shares in Q3 2016, an estimated $4.91M.
  • DexCom made up 0.09% of Emerald Acquisition's portfolio in Q3 2016, its #255 holding.
  • Emerald Acquisition first reported a position in DexCom in Q2 2016 and has held it in 2 quarters since.
  • 289 funds tracked by Wall St. Rank held DexCom as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.